A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 49/00 (2006.01) A61K 39/395 (2006.01) A61K 51/10 (2006.01) C07K 16/00 (2006.01) C07K 16/30 (2006.01) C07K 16/42 (2006.01) A61K 38/00 (2006.01) A61K 43/00 (1990.01)
Patent
CA 2131621
2131621 9318792 PCTABS00025 The present invention relates to a simple process for the modification of, e.g., anti-TAA antibodies, which alters their immunogenicity so that their ability to induce an anti-isotypic response is selectively diminished, while they remain able to elecit an anti-idiotypic response. The latter is of potential immunotherapeutic value, i.e., by activation of the idiotype-anti-idiotype network. This modification takes the form of a controlled and partial reduction of the antibody; effector regions are retained. The invention should permit repeat injections (for diagnosis and therapy) and reduce HAMA interference in serodiagnostic assays.
Baum Richard P.
Noujaim Antoine A.
Reddish Mark A.
Sykes Thomas R.
Biomira Inc.
Smart & Biggar
LandOfFree
Selective alteration of antibody immunogenicity does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Selective alteration of antibody immunogenicity, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Selective alteration of antibody immunogenicity will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1675147